How much does BioMedPartners typically invest?

BioMedPartners states a typical cheque of €1M – €30M.

Which stages does BioMedPartners invest in?

BioMedPartners invests at Seed and Series A.

Where is BioMedPartners based?

BioMedPartners is headquartered in Basel, Switzerland.

Investor directory

BioMedPartners

VC fundBasel, Switzerlandbiomedvc.com LinkedIn

BiomedVC empowers life science entrepreneurs to transform scientific innovations into venture-backed biotech companies.

What they invest in

Stages

Seed Series A

Sectors

Biotech & Pharma HealthTech

Geographies

SwitzerlandGermany

The facts

Typical cheque: €1M – €30M
Headquarters: Basel, Switzerland
Founded: 2002

Portfolio companies

Alentis Therapeutics Azafaros iDEL Therapeutics Noema Pharma Spineart T-Curx TriCares GmbH Tubulis

More portfolio companies

AMAL Therapeutics SACardior Pharmaceuticals GmbHDimericon TherapeuticsImmunOs Therapeutics AGNXI TherapeuticsOmnilinX Therapeutics AGPRECIRIX NVSalvina Therapeutics AGScenic Biotech B.VTOLREMO Therapeutics AGTopas Therapeutics

Questions founders ask

How much does BioMedPartners typically invest?: BioMedPartners states a typical cheque of €1M – €30M.
Which stages does BioMedPartners invest in?: BioMedPartners invests at Seed and Series A.
Where is BioMedPartners based?: BioMedPartners is headquartered in Basel, Switzerland.

Does BioMedPartners fit your round?

In 30 minutes you'll know which funds matter for your round.

Request access

Are you BioMedPartners? Tell us what to correct and we will update it — or ask us to remove the entry.